Atea Pharmaceuticals, Inc. Annual Current Income Tax Expense (Benefit) in USD from 2018 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Atea Pharmaceuticals, Inc. quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from 2018 to 2021.
  • Atea Pharmaceuticals, Inc. Current Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was -$3.83M.
  • Atea Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2021 was $17.4K.
  • Atea Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2020 was $0.000.
  • Atea Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2019 was $0.000.
Current Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $17.4K +$17.4K Jan 1, 2021 Dec 31, 2021 10-K 2022-02-28
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2021-03-30
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.